comparemela.com

Latest Breaking News On - Kelly stock - Page 1 : comparemela.com

A 3x Expected Rise In Mounjaro Sales Is Likely To Drive Eli Lilly s Q1

The pharmaceutical giant is expected to garner $8.9 billion in sales and $2.46 in adjusted earnings per share, per the consensus estimates.

LLY, CVS, EXAS: Which Strong-Buy-Rated Healthcare Stock Is the Better Buy?

The rise of GLP-1 weight-loss drugs has arguably been the second-hottest trend in the stock market right now — second to generative artificial intelligence (AI). Undoubtedly, the “GLP-1 run” has brought a great deal of enthusiasm to the biotechnology and healthcare scenes. However, I don’t expect it’ll be the last ground-breaking innovation from the health space over the coming years. As AI and biotech join forces, there’s no telling where the healthcare scene could be headed next. In any case,

LLY, ABT, CVS: Which Healthcare Stock Do Analysts Prefer?

The healthcare space is an intriguing place to be in these days, with incredible innovations such as GLP-1 drugs (weight-loss drugs like Ozempic and Wegovy) that are rich with growth potential. Additionally, the defensive traits of healthcare stocks make them terrific plays ahead of a potential bout of economic turbulence. Therefore, in this piece, we’ll check in with TipRanks’ Comparison Tool to see which of the following Strong-Buy-rated healthcare stocks analysts prefer for the coming year. E

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.